Overview
Clinical Benefits
- Neurogenesis + synaptic plasticity
- Memory + cognitive enhancement
- TBI / stroke recovery support
- Neurodegeneration risk-reduction stack
Administration
Subcutaneous or intramuscular injection (primary). Intranasal AXIS Elite variant available for direct CNS routing.
Drug class: neuropeptide complex
Clinical Dosing
Typical dosage
5-10mg daily SubQ or IM
Starting dose
5mg
Cadence
1x daily
Full titration schedule
| Phase | Dose |
|---|---|
| Days 1-10 (Loading) | 5mg daily SubQ or IM (0.17 mL from 60 mg / 2 mL vial) |
| Days 11-20 | 10mg daily SubQ or IM (0.33 mL from 60 mg / 2 mL vial) |
| Days 21+ (Rest) | Rest 30-60 days before repeating course |
Safety Profile
Side effects
- • Injection-site tenderness
- • Mild dizziness at loading dose
- • Rare paradoxical agitation
Contraindications
- • Pregnancy
- • Grand mal seizure disorder
- • Severe renal impairment
- • Known allergy to porcine-derived peptides
Featured in these stacks
Frequently asked questions
Cerebrolysin is most commonly researched for: Neurogenesis + synaptic plasticity, Memory + cognitive enhancement, TBI / stroke recovery support, Neurodegeneration risk-reduction stack.
Ready to build a protocol with Cerebrolysin?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.